{"cursor":"5238","size":15,"audio":[],"currentlang":"en","article":"\nThe 'Biopharmaceutics Classification System' are the technique used to\ndifferentiate the drugs on the basis of their solubility and permeability is a\nguide for predicting the intestinal drug absorption provided by the U.S. Food\nand Drug Administration[http://www.fda.gov/]. The fundamental basis for the BCS\nwas established by Gordon Amidon, who was presented with a Distinguished Science\nAward at the August 2006 International Pharmaceutical Federation (FIP) congress\nin Salvador, Brazil.\n\nThis system restricts the prediction using the parameters solubility and\nintestinal permeability. The solubility classification is based on a United\nStates Pharmacopoeia (USP) aperture. The intestinal permeability classification\nis based on a comparison to the intravenous injection. All those factors are\nhighly important because 85% of the most sold drugs in the United States and\nEurope are orally administered.\n\nAccording to the Biopharmaceutics Classification System, drug substances are\nclassified as follows:\n\n*'Class I - high [[intestinal permeability|permeability]], high [[solubility]]'\n** Example: metoprolol ** Those compounds are well absorbed and their absorption\nrate is usually higher than excretion. *'Class II - high permeability, low\nsolubility' ** Example: glibenclamide, bicalutamide, ezetimibe ** The\nbioavailability of those products is limited by their solvation rate. A\ncorrelation between the [[in vivo]] bioavailability and the [[in vitro]]\nsolvation can be found. *'Class III - low permeability, high solubility' **\nExample: cimetidine ** The absorption is limited by the permeation rate but the\ndrug is solvated very fast. If the formulation does not change the permeability\nor gastro-intestinal duration time, then class I criteria can be applied.\n*'Class IV - low permeability, low solubility' ** Example: hydrochlorothiazide\n** Those compounds have a poor bioavailability. Usually they are not well\nabsorbed over the intestinal mucosa and a high variability is expected. \nThe drugs are classified in BCS on the basis of following parameters: \n1. Solubility \n2. Permeability \n3. Dissolution\n\nThe class boundaries for these parameters are:  '1. Solubility class boundaries'-\nIt is based on the highest dose strength of an immediate release product. A drug\nis considered highly soluble when the highest dose strength is soluble in 250 ml\nor less of aqueous media over the pH range of 1 to 7.5. The volume estimate of\n250 ml is derived from typical bioequivalence study protocols that prescribe\nadministration of a drug product to fasting human volunteers with a glass of\nwater.  '2. Permeability class boundaries-' It is based indirectly on the\nextent of absorption of a drug substance in humans and directly on the\nmeasurement of rates of mass transfer across human intestinal membrane.\nAlternatively non-human systems capable of predicting drug absorption in humans\ncan be used (such as in-vitro culture methods). A drug substance is considered\nhighly permeable when the extent of absorption in humans is determined to be 90%\nor more of the administered dose based on a mass-balance determination or in\ncomparison to an intravenous dose.  '3. Dissolution class boundaries-' An\nimmediate release product is considered rapidly dissolving when no less than 85%\nof the labeled amount of the drug substance dissolves within 15 minutes using\nUSP Dissolution Apparatus 1 at 100 RPM or Apparatus 2 at 50 RPM in a volume of\n900 ml or less in the following media: 0.1 N HCl or simulated gastric fluid or\npH 4.5 buffer and pH 6.8 buffer or simulated intestinal fluid.\n","linknr":124,"url":"Biopharmaceutics_Classification_System","recorded":1376416603,"links":["/w/index.php?title=Biopharmaceutics_Classification_System&action=edit","/w/index.php?title=Biopharmaceutics_Classification_System&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Biopharmaceutics_Classification_System","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/BCS_(disambiguation)","/wiki/Gastrointestinal_tract","/wiki/Drug","/wiki/U.S._Food_and_Drug_Administration","http://www.fda.gov/","/w/index.php?title=Gordon_Amidon&action=edit&redlink=1","/wiki/International_Pharmaceutical_Federation","/wiki/Wikipedia:Citation_needed","/wiki/Solubility","/wiki/Intestinal_permeability","/wiki/Solubility","/wiki/United_States_Pharmacopoeia","/wiki/Intestinal_permeability","/wiki/Route_of_administration","/wiki/United_States","/wiki/Europe","/wiki/Route_of_administration","/wiki/Intestinal_permeability","/wiki/Solubility","/wiki/Metoprolol","/wiki/Glibenclamide","/wiki/Bicalutamide","/wiki/Ezetimibe","/wiki/Bioavailability","/wiki/In_vivo","/wiki/In_vitro","/wiki/Cimetidine","/wiki/Hydrochlorothiazide","/w/index.php?title=Biopharmaceutics_Classification_System&action=edit&section=1","/w/index.php?title=Biopharmaceutics_Classification_System&veaction=edit&section=1","/wiki/ADME","/wiki/Partition_coefficient","/wiki/Bioavailability","/wiki/Drug_metabolism","/wiki/First_pass_effect","/wiki/Polar_surface_area","/wiki/IVIVC","/w/index.php?title=Biopharmaceutics_Classification_System&action=edit&section=2","/w/index.php?title=Biopharmaceutics_Classification_System&veaction=edit&section=2","/wiki/International_Standard_Book_Number","/wiki/Special:BookSources/3-527-30438-X","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/7617530","/w/index.php?title=Biopharmaceutics_Classification_System&action=edit&section=3","/w/index.php?title=Biopharmaceutics_Classification_System&veaction=edit&section=3","http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm128219.htm","/wiki/U.S._Food_and_Drug_Administration","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Biopharmaceutics_Classification_System&oldid=556178801","/wiki/Help:Category","/wiki/Category:Pharmacology","/wiki/Category:Pharmacy_in_the_United_States","/wiki/Category:All_articles_with_unsourced_statements","/wiki/Category:Articles_with_unsourced_statements_from_February_2007","/w/index.php?title=Special:UserLogin&returnto=Biopharmaceutics+Classification+System&type=signup","/w/index.php?title=Special:UserLogin&returnto=Biopharmaceutics+Classification+System","/wiki/Biopharmaceutics_Classification_System","/wiki/Talk:Biopharmaceutics_Classification_System","#","/wiki/Biopharmaceutics_Classification_System","/w/index.php?title=Biopharmaceutics_Classification_System&action=edit","/w/index.php?title=Biopharmaceutics_Classification_System&veaction=edit","/w/index.php?title=Biopharmaceutics_Classification_System&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Biopharmaceutics_Classification_System","/wiki/Special:RecentChangesLinked/Biopharmaceutics_Classification_System","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Biopharmaceutics_Classification_System&oldid=556178801","/w/index.php?title=Biopharmaceutics_Classification_System&action=info","//www.wikidata.org/wiki/Q278760","/w/index.php?title=Special:Cite&page=Biopharmaceutics_Classification_System&id=556178801","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Biopharmaceutics+Classification+System","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Biopharmaceutics+Classification+System&oldid=556178801&writer=rl","/w/index.php?title=Biopharmaceutics_Classification_System&printable=yes","//ar.wikipedia.org/wiki/%D9%86%D8%B8%D8%A7%D9%85_%D8%AA%D8%B5%D9%86%D9%8A%D9%81_%D8%A7%D9%84%D8%B5%D9%8A%D8%AF%D9%84%D8%A7%D9%86%D9%8A%D8%A7%D8%AA_%D8%A7%D9%84%D8%A8%D9%8A%D9%88%D9%84%D9%88%D8%AC%D9%8A%D8%A9","//de.wikipedia.org/wiki/Biopharmazeutisches_Klassifizierungssystem","//pl.wikipedia.org/wiki/System_klasyfikacji_biofarmaceutycznej","#","//www.wikidata.org/wiki/Q278760#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Biopharmaceutics_Classification_System","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Pharmacology","Pharmacy in the United States"],"headings":["See also","References","External links"],"image":["//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Gastrointestinal_tract","Drug","U.S._Food_and_Drug_Administration","Gordon_Amidon","International_Pharmaceutical_Federation","Solubility","Intestinal_permeability","Solubility","United_States_Pharmacopoeia","Intestinal_permeability","Route_of_administration","United_States","Europe","Route_of_administration","Metoprolol","Glibenclamide","Bicalutamide","Ezetimibe","Bioavailability","Cimetidine","Hydrochlorothiazide","ADME","Partition_coefficient","Bioavailability","Drug_metabolism","First_pass_effect","Polar_surface_area","IVIVC","U.S._Food_and_Drug_Administration"]}